Scroll Back to Top
Accessibility
Accessibility

Rebecca Previs, MD, MS

Sr Medical Director, Oncology - Chapel Hill, NC
Email Call 804-338-6903
https://www.linkedin.com/in/rebecca-previs-190bb422b/" aria-label="LinkedIN" target="_blank">View on LinkedIn

Dr. Rebecca Previs is a board-certified gynecologic oncologist and the Senior Medical Director at Labcorp Oncology, where she leads the medical affairs team and strategic oncology initiatives to advance precision medicine and improve cancer diagnostics and care delivery. She also serves as an Adjunct Assistant Professor of Obstetrics & Gynecology and Gynecologic Oncology at Duke University Medical Center.

Prior to joining Labcorp, Dr. Previs was an Assistant Professor and principal investigator at Duke, where she led early phase clinical trials translational research focused on biomarkers and the immune microenvironment in gynecologic cancers. Her work has been supported by grant funding from the NIH, Duke WRHR K12 Program, AAGOF-GOG Foundation, and Emerson Collective. She has mentored numerous trainees and served on national advisory committees, including NRG Oncology.

Dr. Previs completed her fellowship in gynecologic oncology at MD Anderson Cancer Center and holds a Master of Science in Cancer Biology. Prior to that, she completed her residency in Obstetrics & Gynecologic at Duke University Medical Center. Her career reflects a deep commitment to advancing women’s health through research, education, and clinical innovation.

https://www.ncbi.nlm.nih.gov/myncbi/1tS7shBBeag5X/bibliography/public/

Areas of Support: Molecular Oncology

Memberships: ASCO; SGO

Board Certifications:

  • American Board of Obstetrics and Gynecology, 

Board Certified in Obstetrics and Gynecology: 2018 through present 

Board Certified in Gynecologic Oncology: 2021 through present 

  • North Carolina State Medical License – 2009-2013; 2017-present

Notable Roles:

Notable Roles:

Prior to joining Labcorp as the Director of Medical Affairs, she was an Assistant Professor of Gynecologic Oncology at Duke Cancer Institute and Duke University School of Medicine. As the principal investigator of an externally-funded translational laboratory, her work focused on pre-clinical development of novel cancer therapies and tumor immune microenvironment. 

Upon completion of her training, Dr. Previs joined the Division of Gynecologic Oncology at Duke University, where she operated on patients with newly diagnosed or suspected gynecologic cancers. Her clinical practice focused enrolling patients with recurrent cancer on early phase and immuno-oncology clinical trials. Becca maintains an adjunct faculty appointment at Duke within the Department of Obstetrics & Gynecology, Division of Gynecologic Oncology in Durham, North Carolina. 

 

Education:

Education:

  • Fellowship, Gynecologic Oncology - The University of Texas MD Anderson Cancer Center
  • Master of Science - The University of Texas, Graduate School of Biomedical Sciences, Cancer Biology
  • Resident, Obstetrics and Gynecology - Duke University Medical Center
  • MD - University of Virginia
  • BS, BA - University of Richmond, Majored in Chemistry and Rhetoric and Communications; Minored in Biology and Women’s Studies

Publications:

BiosMDFunctionMedical AffairsCancers & tumorsOncology